東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The Canadian pharmaceutical patent r...

Babin, Dominique.

FindBook

Google Book

Amazon

博客來

The Canadian pharmaceutical patent regime in the world trading system.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The Canadian pharmaceutical patent regime in the world trading system./
作者:	Babin, Dominique.
面頁冊數:	120 p.
附註:	Advisers: David Lametti; Ysolde Gendreau.
Contained By:	Masters Abstracts International41-01.
標題:	Health Sciences, Pharmacy. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ70537
ISBN:	0612705374

The Canadian pharmaceutical patent regime in the world trading system.
Babin, Dominique.

The Canadian pharmaceutical patent regime in the world trading system. - 120 p.

Advisers: David Lametti; Ysolde Gendreau.

Thesis (LL.M.)--McGill University (Canada), 1999.

In 1994, the members of the World Trade Organisation (WTO) adopted the Agreement on Trade-Related Aspects of Intellectual Property (the “TRIPs Agreement”) and thus committed themselves to respect certain standards for intellectual property protection. This thesis studies the scope of the standards for patent protection and their impact upon trade in medicines. The first part addresses the international dimension of the issue and explains how international trade in medicines can contribute to enhancing the level of global welfare. The first chapter argues that in order to fulfil this latter objective legislation relating to patents must be adapted to the economic and social situation of countries. The second chapter demonstrates that such adaptation is not only allowed, but is indeed encouraged by the provisions of the TRIPS Agreement. The second part of this thesis addresses the issue from a Canadian perspective, and discusses the way Canadian patent provisions applying to pharmaceuticals should be drafted so as to allow Canada to participate in—and to benefit from—international trade in medicines. Thus, I first analyse the factual, political, and legislative factors that influence the Canadian pharmaceutical industry. I then study the role of Canada as part of the integrated market for medicines, as well as the social, industrial and economic objectives underlying Canadian policies. I finally propose some modifications and adaptations to the Canadian Patent Act and suggest some orientations for future multilateral negotiations.

ISBN: 0612705374Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

The Canadian pharmaceutical patent regime in the world trading system.
LDR:02508nam 2200301 a 45 001 931891
005 20110429
008 110429s1999 eng d
020 $a 0612705374
035 $a (UnM)AAIMQ70537
035 $a AAIMQ70537
040 $a UnM $c UnM
100 1 $a Babin, Dominique. $3 1255465
245 1 0 $a The Canadian pharmaceutical patent regime in the world trading system.
300 $a 120 p.
500 $a Advisers: David Lametti; Ysolde Gendreau.
500 $a Source: Masters Abstracts International, Volume: 41-01, page: 0081.
502 $a Thesis (LL.M.)--McGill University (Canada), 1999.
520 $a In 1994, the members of the World Trade Organisation (WTO) adopted the Agreement on Trade-Related Aspects of Intellectual Property (the “TRIPs Agreement”) and thus committed themselves to respect certain standards for intellectual property protection. This thesis studies the scope of the standards for patent protection and their impact upon trade in medicines. The first part addresses the international dimension of the issue and explains how international trade in medicines can contribute to enhancing the level of global welfare. The first chapter argues that in order to fulfil this latter objective legislation relating to patents must be adapted to the economic and social situation of countries. The second chapter demonstrates that such adaptation is not only allowed, but is indeed encouraged by the provisions of the TRIPS Agreement. The second part of this thesis addresses the issue from a Canadian perspective, and discusses the way Canadian patent provisions applying to pharmaceuticals should be drafted so as to allow Canada to participate in—and to benefit from—international trade in medicines. Thus, I first analyse the factual, political, and legislative factors that influence the Canadian pharmaceutical industry. I then study the role of Canada as part of the integrated market for medicines, as well as the social, industrial and economic objectives underlying Canadian policies. I finally propose some modifications and adaptations to the Canadian Patent Act and suggest some orientations for future multilateral negotiations.
590 $a School code: 0781.
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Law. $3 600858
650 4 $a Political Science, International Law and Relations. $3 1017399
690 $a 0398
690 $a 0572
690 $a 0616
710 2 0 $a McGill University (Canada). $3 1018122
773 0 $t Masters Abstracts International $g 41-01.
790 $a 0781
790 1 0 $a Gendreau, Ysolde, $e advisor
790 1 0 $a Lametti, David, $e advisor
791 $a LL.M.
792 $a 1999
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ70537